Ronald W. Mcclurg serves as Executive at NEUROONE MEDICAL TECHNOLOGIES Corp, where they oversee executive responsibilities. Since joining the company, Ronald W. Mcclurg has executed 8 insider transactions totaling $100.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 18, 2024 involved receiving (via award) 113,717 shares valued at $0.
Ronald W. Mcclurg currently holds 244,117 shares of NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ronald W. Mcclurg has been a net buyer of NMTC stock. They have purchased $100.1K and sold $0 worth of shares.
Ronald W. Mcclurg's most recent insider trade was on Feb 18, 2024, when they sold 113,717 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.98 |
| Discretionary |
| Apr 21, 2023 | NMTC | $0 | Award | 12,500 | $N/A | Discretionary |
| Jun 15, 2022 | NMTC | $10.2K | Purchase | 10,000 | $1.02 | Discretionary |
| Jun 10, 2022 | NMTC | $14.8K | Purchase | 14,000 | $1.06 | Discretionary |
| May 24, 2022 | NMTC | $10.3K | Purchase | 10,500 | $0.98 | Discretionary |
| May 20, 2022 | NMTC | $14.9K | Purchase | 17,500 | $0.85 | Discretionary |
| Feb 3, 2022 | NMTC | $0 | Award | 15,000 | $N/A | Discretionary |